We are analyzing https://link.springer.com/article/10.1007/s00296-007-0388-4.

Title:
Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis | Rheumatology International
Description:
The purpose of this study was to analyze the effect of the soluble TNF-α receptor etanercept on the serum levels of IL-16, IL-17, IL-23, and macrophage inflammatory protein-3α (MIP-3α) in rheumatoid arthritis (RA) patients. Twenty-two patients with RA were administered etanercept once or twice a week for more than 6 months, and we evaluated clinical and laboratory parameters and serum levels of IL-16, IL-17, IL-23, and MIP-3α at the baseline and at 3 and 6 months. Additionally, the production of IL-23 and MIP-3α of cultured synovial cells stimulated with TNF-α from RA patients was determined by ELISA. We also used ELISA kits to determine synovial fluid (SF) levels of IL-17, IL-23, and MIP-3α in patients with RA, osteoarthritis (OA), pseudogouty arthritis (PGA), and gouty arthritis (GA). A significant decrease in serum levels of IL-23 and MIP-3α was observed at 3 and 6 months after initial treatment of etanercept. TNF-α induced MIP-3α but not IL-23 production in cultured synovial cells from RA patients. SF levels of IL-17, IL-23, and MIP-3α in RA patients showed significantly higher levels than those of OA, PGA, and GA patients. This study demonstrated that the reduction of IL-23 and MIP-3α production in RA patients was a newly determined function of etanercept
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, arthritis, rheumatoid, patients, immunol, alpha, production, interleukin, levels, cells, inflammatory, protein, receptor, etanercept, serum, macrophage, mipα, factor, chemokine, necrosis, human, kageyama, access, clin, privacy, cookies, content, ichikawa, soluble, synovial, treatment, rheum, therapy, med, kim, exp, ccr, autoimmune, expression, publish, search, rheumatology, reduces, nagafusa, torikai, nagano,

Topics {✒️}

anti-tumour necrosis factor tnf-dependent nf-kappab activation masahiro shimazu & akira nagano month download article/chapter tnf-α induced mip-3α macrophage inflammatory protein-3α inhibits tnf-induced accumulation ameliorates autoimmune encephalomyelitis anti-tnf alpha therapy cyclosporin a-sensitive mechanism mip-3alpha/larc/exodus cc chemokine mip-3alpha anti-inflammatory cytokine full article pdf macrophage inhibitory protein-3 macrophage proinflammatory chemokine anti-cytokine therapy privacy choices/manage cookies cc chemokine receptor il-23-mediated il-17 production rheumatoid synoviocyte activation th17 immune responses repeated infliximab therapy receptor internalization attenuates related subjects necrotic cell death dieu mc decreases chemokine expression lung dendritic cells ccl20 chemokine induces coordinated cytokine expression joint autoimmune inflammation il17 soluble receptors human dendritic cells cultured synovial cells rheumatoid arthritis patients european economic area inflamed epithelial surfaces klebsiella pneumoniae infection article kageyama etanercept reduces determine synovial fluid conditions privacy policy mip-3α production serum matrix metalloproteinases tnf inhibition rapidly metastatic breast cancer subchondral bone tissue de waal malefyt mip-3alpha/ccl20

Questions {❓}

Feldmann M, Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis
         description:The purpose of this study was to analyze the effect of the soluble TNF-α receptor etanercept on the serum levels of IL-16, IL-17, IL-23, and macrophage inflammatory protein-3α (MIP-3α) in rheumatoid arthritis (RA) patients. Twenty-two patients with RA were administered etanercept once or twice a week for more than 6 months, and we evaluated clinical and laboratory parameters and serum levels of IL-16, IL-17, IL-23, and MIP-3α at the baseline and at 3 and 6 months. Additionally, the production of IL-23 and MIP-3α of cultured synovial cells stimulated with TNF-α from RA patients was determined by ELISA. We also used ELISA kits to determine synovial fluid (SF) levels of IL-17, IL-23, and MIP-3α in patients with RA, osteoarthritis (OA), pseudogouty arthritis (PGA), and gouty arthritis (GA). A significant decrease in serum levels of IL-23 and MIP-3α was observed at 3 and 6 months after initial treatment of etanercept. TNF-α induced MIP-3α but not IL-23 production in cultured synovial cells from RA patients. SF levels of IL-17, IL-23, and MIP-3α in RA patients showed significantly higher levels than those of OA, PGA, and GA patients. This study demonstrated that the reduction of IL-23 and MIP-3α production in RA patients was a newly determined function of etanercept
         datePublished:2007-07-10T00:00:00Z
         dateModified:2007-07-10T00:00:00Z
         pageStart:137
         pageEnd:143
         sameAs:https://doi.org/10.1007/s00296-007-0388-4
         keywords:
            Etanercept
            Rheumatoid arthritis
            IL-23
            MIP-3α
            Rheumatology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00296-007-0388-4/MediaObjects/296_2007_388_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00296-007-0388-4/MediaObjects/296_2007_388_Fig2_HTML.gif
         isPartOf:
            name:Rheumatology International
            issn:
               1437-160X
               0172-8172
            volumeNumber:28
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yasunori Kageyama
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Tetsuya Ichikawa
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tetsuyuki Nagafusa
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eiji Torikai
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masahiro Shimazu
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Nagano
               affiliation:
                     name:Hamamatsu University School of Medicine
                     address:
                        name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis
      description:The purpose of this study was to analyze the effect of the soluble TNF-α receptor etanercept on the serum levels of IL-16, IL-17, IL-23, and macrophage inflammatory protein-3α (MIP-3α) in rheumatoid arthritis (RA) patients. Twenty-two patients with RA were administered etanercept once or twice a week for more than 6 months, and we evaluated clinical and laboratory parameters and serum levels of IL-16, IL-17, IL-23, and MIP-3α at the baseline and at 3 and 6 months. Additionally, the production of IL-23 and MIP-3α of cultured synovial cells stimulated with TNF-α from RA patients was determined by ELISA. We also used ELISA kits to determine synovial fluid (SF) levels of IL-17, IL-23, and MIP-3α in patients with RA, osteoarthritis (OA), pseudogouty arthritis (PGA), and gouty arthritis (GA). A significant decrease in serum levels of IL-23 and MIP-3α was observed at 3 and 6 months after initial treatment of etanercept. TNF-α induced MIP-3α but not IL-23 production in cultured synovial cells from RA patients. SF levels of IL-17, IL-23, and MIP-3α in RA patients showed significantly higher levels than those of OA, PGA, and GA patients. This study demonstrated that the reduction of IL-23 and MIP-3α production in RA patients was a newly determined function of etanercept
      datePublished:2007-07-10T00:00:00Z
      dateModified:2007-07-10T00:00:00Z
      pageStart:137
      pageEnd:143
      sameAs:https://doi.org/10.1007/s00296-007-0388-4
      keywords:
         Etanercept
         Rheumatoid arthritis
         IL-23
         MIP-3α
         Rheumatology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00296-007-0388-4/MediaObjects/296_2007_388_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00296-007-0388-4/MediaObjects/296_2007_388_Fig2_HTML.gif
      isPartOf:
         name:Rheumatology International
         issn:
            1437-160X
            0172-8172
         volumeNumber:28
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yasunori Kageyama
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Tetsuya Ichikawa
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tetsuyuki Nagafusa
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eiji Torikai
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masahiro Shimazu
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Nagano
            affiliation:
                  name:Hamamatsu University School of Medicine
                  address:
                     name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Rheumatology International
      issn:
         1437-160X
         0172-8172
      volumeNumber:28
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
      name:Hamamatsu University School of Medicine
      address:
         name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yasunori Kageyama
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Tetsuya Ichikawa
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
      name:Tetsuyuki Nagafusa
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
      name:Eiji Torikai
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
      name:Masahiro Shimazu
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
      name:Akira Nagano
      affiliation:
            name:Hamamatsu University School of Medicine
            address:
               name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
      name:Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(156)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4s.

LINK . SPRINGER . COM {}